[Therapeutic response to pyridoxine and pyridostigmine in a paediatric case of severe peripheral and cranial polyneuropathy due to vincristine]

Rev Neurol. 2015 Jan 16;60(2):91-2.
[Article in Spanish]
No abstract available

Publication types

  • Case Reports
  • English Abstract
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Asparaginase / administration & dosage
  • Blepharoptosis / chemically induced
  • Blepharoptosis / drug therapy
  • Cranial Nerve Diseases / chemically induced
  • Cranial Nerve Diseases / drug therapy*
  • Daunorubicin / administration & dosage
  • Diagnosis, Differential
  • Esotropia / chemically induced
  • Esotropia / drug therapy
  • Female
  • Guillain-Barre Syndrome / diagnosis
  • Humans
  • Imatinib Mesylate / administration & dosage
  • Infant
  • Peripheral Nervous System Diseases / chemically induced
  • Peripheral Nervous System Diseases / diagnosis
  • Peripheral Nervous System Diseases / drug therapy*
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / complications
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
  • Prednisone / administration & dosage
  • Pyridostigmine Bromide / therapeutic use*
  • Pyridoxine / therapeutic use*
  • Quadriplegia / chemically induced
  • Quadriplegia / drug therapy
  • Vincristine / administration & dosage
  • Vincristine / adverse effects*

Substances

  • Vincristine
  • Imatinib Mesylate
  • Asparaginase
  • Pyridoxine
  • Pyridostigmine Bromide
  • Prednisone
  • Daunorubicin